Needham Raises Synopsys Target and Cuts Enovis Target
Needham kept Buy ratings on Synopsys and Enovis, raising SNPS’s target to $620 while cutting ENOV’s target to $34 per share.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Dow Jones Newswires, citing rating actions published by Benzinga, reported that Needham maintained its Buy rating on Synopsys. The firm raised its price target for the company to $620.00 per share from $580.00. The update was published at 09:54 GMT on Oct. 12, 2026.
Needham also maintained a Buy rating on Enovis, but reduced its price target to $34.00 per share from $52.00. Dow Jones Newswires reported the action at 10:22 GMT on Oct. 12, 2026, also citing Benzinga.
why it matters
The target-price changes show a diverging reassessment by Needham: the Synopsys target was increased, while the Enovis target was cut substantially, even though both Buy ratings were maintained.
instruments
sources
- Synopsys Is Maintained at Buy by Needham — Dow Jones Newswires, 12 October 2026 at 09:54 UTC
- Enovis Is Maintained at Buy by Needham — Dow Jones Newswires, 12 October 2026 at 10:22 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗